SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 125 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $246,000 | +12.3% | 20,000 | 0.0% | 0.00% | +33.3% |
Q2 2016 | $219,000 | 0.0% | 20,000 | 0.0% | 0.00% | -25.0% |
Q1 2016 | $219,000 | -36.7% | 20,000 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $346,000 | -15.0% | 20,000 | -2.4% | 0.01% | -33.3% |
Q3 2015 | $407,000 | -38.8% | 20,500 | -49.4% | 0.01% | -30.8% |
Q2 2015 | $665,000 | +6.9% | 40,500 | +1.2% | 0.01% | 0.0% |
Q1 2015 | $622,000 | -66.6% | 40,000 | -69.3% | 0.01% | -69.0% |
Q4 2014 | $1,864,000 | +119.8% | 130,500 | 0.0% | 0.04% | +100.0% |
Q3 2014 | $848,000 | -5.8% | 130,500 | 0.0% | 0.02% | -12.5% |
Q2 2014 | $900,000 | -3.5% | 130,500 | 0.0% | 0.02% | -11.1% |
Q1 2014 | $933,000 | -24.0% | 130,500 | 0.0% | 0.03% | -27.0% |
Q4 2013 | $1,227,000 | +50.7% | 130,500 | 0.0% | 0.04% | +32.1% |
Q3 2013 | $814,000 | +17.0% | 130,500 | +23.3% | 0.03% | 0.0% |
Q2 2013 | $696,000 | – | 105,800 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |